206 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
and other liabilities
Long-term incentive plan accrual
Accrued compensation
Income taxes receivable and payable, net
Contract liabilities
Net cash used
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
assesses the long- term safety and efficacy of the ACAM2000 Lyophilized Drug Product at the Strategic National Stockpile and supports [**] of shelf … and will not be distributed for any use. Given the commitment for a long-term contract to replace the stockpile, Emergent will agree to test representative
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
, Sustainable Long-Term Growth Closing Remarks Q&A
PROPRIETARY AND CONFIDENTIAL Q1 2024 Update Transformation Plan Update Joseph C. Papa President and Chief … % of Revenue Weighted avg. fully diluted share count ~52 Capex ~$32 Depreciation & amortization ~$111
Driving Profitable, Sustainable Long- Term Growth
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
4:05pm
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
Proactive changes aim to ensure long-term sustainability … and long-term success, and that starts by stabilizing our operations, strengthening our balance sheet and managing our debt.”
Papa continued, “Decisions
8-K
EX-99.2
rf51jf htts0pvfb
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
ff3q q1hj9t9
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
24q xgyux2pe
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-99.1
3kdxg
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.1
i66 qniwuc6bgd
31 Jul 23
Other Events
4:26pm
8-K
EX-10.1
e67b2o g967ygd
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
8-K
EX-99.1
7pvyq
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
8-K
EX-99.1
4cpzda4 73bvs
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
8-K
EX-99.2
5qxlme3adnfnf1071
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm